Literature DB >> 11149548

Management of myxedematous respiratory failure: review of ventilation and weaning principles.

M Behnia, A S Clay, M O Farber.   

Abstract

Respiratory failure in myxedema is a complex medical emergency and may require prolonged ventilatory assistance. Appropriate management of this medical problem requires an understanding of its effects on the central nervous system and peripheral neuromusculoskeletal system. Weaning of these patients can be very protracted and requires a diligent multidisciplinary approach. Because of its infrequency, ventilatory management of severe hypothyroidism has not been studied in a controlled fashion. The first part of this review discusses the mechanisms of respiratory failure in myxedema. The second part explores strategies in mechanical ventilation and weaning of myxedematous patients.

Entities:  

Mesh:

Year:  2000        PMID: 11149548     DOI: 10.1097/00000441-200012000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Easy yet so easily missed.

Authors:  A K Siotia; R Muthusamy
Journal:  BMJ       Date:  2005-05-07

2.  Respiratory failure was improved by growth hormone substitution in a patient with hypopituitarism.

Authors:  Ikuko Sato; Yutaka Yokoyama; Misaki Ryuge; Hiroyuki Taniguchi; Hiroshi Arima; Shuko Yoshioka
Journal:  BMJ Case Rep       Date:  2010-08-19

3.  Respiratory failure associated with hypoventilation in a patient with severe hypothyroidism.

Authors:  Munehisa Fukusumi; Toshiko Iidaka; Atsuto Mouri; Yoichiro Hamamoto; Mitsuhiro Kamimura
Journal:  Respirol Case Rep       Date:  2014-03-13

4.  Growth hormone replacement therapy improves hypopituitarism-associated hypoxemia in a patient after craniopharyngioma surgery: A case report.

Authors:  Wenting Qi; Feng Gu; Chuyue Wu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 5.  Clinical review: liberation from mechanical ventilation.

Authors:  Mohamad F El-Khatib; Pierre Bou-Khalil
Journal:  Crit Care       Date:  2008-08-06       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.